1Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation, 2002,105(5) :546.
2LaBElle EF, Tulenko TN. LDL, IGF, and VSMC apoptosis: linking atherogenersis to plaque rupture in vulnerable lesions. Cardiovasc Res,2004, 61(2): 204.
3Zaman AG, Worthley SG. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis, 2000,149(2):251.
4Pearson TA, Mensah GA, Alexander RW et al. Markers of inflammation and cardioascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation,2003,107(3):499.
5Verma S, Li SH, Badiwala MV et al. Endothelin antagonism andinterleukin-6inhibition attenuate the proatherogenic effects of C -reactive prorein. Circulation, 2002,105(16) : 1890.
6Phipps RP. Atherosclerosis: the emerging role of inflammation and the CD40/CD40L system. Proc Natl Acad Sci USA. 2000,97(1) : 6930.
7Yamashia H, Shimada K, Seki E et al. Concentratins of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris.Am J Cardiol,2003,91(2) : 133.
8Whitman SC, Ravisankar P, Daugherty A. Interleukin-18 enhance atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-γ.Circ Res,2002,90(1) :34.
10Aria T E, Outi N, Seppo L et al. Autoantibodies against oxidized low density [ipoprotein and cardiolipin in patients with coronary heart disease.Arterioscler Thromb Vasc Bio, 2000,20(2):204.
